Kamiya et al. found that the etiology-specific survival rate of patients with tumor metastasis and high levels of NSE in the body was significantly reduced (P<0.05), and serum NSE as an independent variable was associated with the risk of death (P<0.05) [30]. The gene discussed is ENO2; the disease is neoplasm.